Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Dutasteride may help reduce brain inflammation and improve cognition.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.